Manufacturer record
Relief Biotech Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Relief Biotech Pvt. Ltd (Delhi) were declared Not of Standard Quality between March 2023 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
11 records linked to Relief Biotech Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan Tablets IP 40mg | RT-251154Mfg 2025-11 · Exp 2027-10 | 1. Description 2. Dissolution (7Units Foumd to be less than 60% against I.P Limit of max. Two Units to be less than 60% against labeled claim also 7units found to be less than 50% against I.P Limit of No Unit to be less than 50% against Labeled claim.)Dissolution | SDTL, PunjabState lab | Jun 2026 |
| Norfloxacin Tablets IP 400 mg | RT-250413Mfg 2025-04 · Exp 2027-03 | ContentOther | DTL, Madurai-19State lab | May 2026 |
| Atorvastatin Tablets IP 10mg | RT - 250622Mfg 2025-06 · Exp 2027-05 | DissolutionDissolution | DTL, Chennai-06State lab | May 2026 |
| Amlodipine Tablets IP 5mg | RT-251061Mfg 2025-10 · Exp 2027-09 | ContentOther | DTL,Chennai-06State lab | Feb 2026 |
| Atorvastatin Tablets IP 10mg | RT-250560Mfg 2025-05 · Exp 2027-04 | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
| Amlodipine Tablets IP 5mg | RT-2505104Mfg 2025-05 · Exp 2027-04 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
| Telmisartan Tablets IP 40mg | RT-250582Mfg 2025-05 · Exp 2027-04 | DescriptionDescription | State Drugs Laboratory, PunjabState lab | Jul 2025 |
| Ramipril Tablets I.P. 2.5 mg | RT-231084Mfg 2023-10 · Exp 2025-09 | Assay of RamiprilAssay | RDTL GuwahatiCDSCO lab | Sep 2024 |
| Vitamin B Complex Tablets | RT-220598Mfg 2022-05 · Exp 2023-10 | Description and Assay of Thiamine HydrochlorideAssay | CDL KolkataCDSCO lab | Mar 2023 |
| Calcium & Vitamin D3 Tablets I. P. | RT-221004Mfg 2022-10 · Exp 2024-03 | Identification and Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Mar 2023 |
| Calcium & Vitamin D3 Tablets I.P. | RT-221008Mfg 2022-10 · Exp 2024-03 | Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Mar 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.